Mononuclear	JJ	B-NP	B-cell_type	Other	###	1	Mononuclear	Mononuclear	JJ	JJ	_	2	amod	_	_
leukocyte	NN	I-NP	I-cell_type	Other	###	2	leukocyte	leukocyte	NN	NN	_	0	root	_	_
glucocorticoid	NN	I-NP	B-protein	B-Protein	###	3	glucocorticoid	glucocorticoid	NN	NN	_	2	compound	_	_
receptor	NN	I-NP	I-protein	I-Protein	###	4	receptor	receptor	NN	NN	_	2	dep	_	_
binding	NN	I-NP	O	Other	###	5	binding	binding	NN	NN	_	6	compound	_	_
characteristics	NNS	I-NP	O	Other	###	6	characteristics	characteristics	NNS	NNS	_	2	dep	_	_
and	CC	O	O	Other	###	7	and	and	CC	CC	_	2	cc	_	_
down-regulation	NN	B-NP	O	Other	###	8	down-regulation	down-regulation	NN	NN	_	6	conj	_	_
in	IN	B-PP	O	Other	###	9	in	in	IN	IN	_	11	case	_	_
major	JJ	B-NP	O	Other	###	10	major	major	JJ	JJ	_	11	amod	_	_
depression	NN	I-NP	O	Other	###	11	depression	depression	NN	NN	_	2	nmod	_	_
.	.	O	O	Other	###	12	.	.	.	.	_	2	punct	_	_

Some	DT	B-NP	O	Other	###	1	Some	Some	DT	DT	_	2	det	_	_
patients	NNS	I-NP	O	Other	###	2	patients	patients	NNS	NNS	_	10	nsubj	_	_
with	IN	B-PP	O	Other	###	3	with	with	IN	IN	_	6	case	_	_
major	JJ	B-NP	O	Other	###	4	major	major	JJ	JJ	_	6	amod	_	_
depressive	JJ	I-NP	O	Other	###	5	depressive	depressive	JJ	JJ	_	6	amod	_	_
disorder	NN	I-NP	O	Other	###	6	disorder	disorder	NN	NN	_	2	nmod	_	_
(	(	O	O	Other	###	7	(	(	(	(	_	8	punct	_	_
MDD	NN	B-NP	O	Other	###	8	MDD	MDD	NN	NN	_	6	appos	_	_
)	)	O	O	Other	###	9	)	)	)	)	_	8	punct	_	_
have	VBP	B-VP	O	Other	###	10	have	have	VBP	VBP	_	0	root	_	_
elevated	VBN	I-VP	O	Other	###	11	elevated	elevated	VBN	VBN	_	14	amod	_	_
plasma	NN	B-NP	O	Other	###	12	plasma	plasma	NN	NN	_	14	compound	_	_
cortisol	NN	I-NP	O	Other	###	13	cortisol	cortisol	NN	NN	_	14	compound	_	_
concentrations	NNS	I-NP	O	Other	###	14	concentrations	concentrations	NNS	NNS	_	10	dobj	_	_
and	CC	O	O	Other	###	15	and	and	CC	CC	_	10	cc	_	_
show	VBP	B-VP	O	Other	###	16	show	show	VBP	VBP	_	10	conj	_	_
failure	NN	B-NP	O	Other	###	17	failure	failure	NN	NN	_	16	dobj	_	_
to	TO	B-VP	O	Other	###	18	to	to	TO	TO	_	19	mark	_	_
suppress	VB	I-VP	O	Other	###	19	suppress	suppress	VB	VB	_	17	acl	_	_
cortisol	NN	B-NP	O	Other	###	20	cortisol	cortisol	NN	NN	_	21	compound	_	_
secretion	NN	I-NP	O	Other	###	21	secretion	secretion	NN	NN	_	19	dobj	_	_
upon	IN	B-PP	O	Other	###	22	upon	upon	IN	IN	_	23	case	_	_
administration	NN	B-NP	O	Other	###	23	administration	administration	NN	NN	_	19	nmod	_	_
of	IN	B-PP	O	Other	###	24	of	of	IN	IN	_	25	case	_	_
dexamethasone	NN	B-NP	O	Other	###	25	dexamethasone	dexamethasone	NN	NN	_	23	nmod	_	_
(	(	O	O	Other	###	26	(	(	(	(	_	27	punct	_	_
DEX	NN	B-NP	O	Other	###	27	DEX	DEX	NN	NN	_	25	appos	_	_
)	)	O	O	Other	###	28	)	)	)	)	_	27	punct	_	_
,	,	O	O	Other	###	29	,	,	,	,	_	10	punct	_	_
yet	RB	B-ADVP	O	Other	###	30	yet	yet	RB	RB	_	10	cc	_	_
they	PRP	B-NP	O	Other	###	31	they	they	PRP	PRP	_	34	nsubj	_	_
do	VBP	B-VP	O	Other	###	32	do	do	VBP	VBP	_	34	aux	_	_
not	RB	I-VP	O	Other	###	33	not	not	RB	RB	_	34	neg	_	_
have	VB	I-VP	O	Other	###	34	have	have	VB	VB	_	10	parataxis	_	_
Cushingoid	JJ	B-NP	O	Other	###	35	Cushingoid	Cushingoid	JJ	JJ	_	36	amod	_	_
features	NNS	I-NP	O	Other	###	36	features	features	NNS	NNS	_	34	dobj	_	_
.	.	O	O	Other	###	37	.	.	.	.	_	10	punct	_	_

To	TO	B-VP	O	Other	###	1	To	To	TO	TO	_	2	mark	_	_
study	VB	I-VP	O	Other	###	2	study	study	VB	VB	_	0	root	_	_
whether	IN	B-SBAR	O	Other	###	3	whether	whether	IN	IN	_	5	mark	_	_
this	DT	B-NP	O	Other	###	4	this	this	DT	DT	_	5	nsubj	_	_
represents	VBZ	B-VP	O	Other	###	5	represents	represents	VBZ	VBZ	_	2	ccomp	_	_
glucocorticoid	NN	B-NP	O	Other	###	6	glucocorticoid	glucocorticoid	NN	NN	_	10	compound	_	_
(	(	O	O	Other	###	7	(	(	(	(	_	8	punct	_	_
GC	NN	B-NP	O	Other	###	8	GC	GC	NN	NN	_	6	appos	_	_
)	)	O	O	Other	###	9	)	)	)	)	_	8	punct	_	_
resistance	NN	B-NP	O	Other	###	10	resistance	resistance	NN	NN	_	5	dobj	_	_
,	,	O	O	Other	###	11	,	,	,	,	_	2	punct	_	_
[	(	O	O	Other	###	12	[	[	(	(	_	2	parataxis	_	_
3H	NN	B-NP	O	Other	###	13	3H	3H	NN	NN	_	17	compound	_	_
]	)	I-NP	O	Other	###	14	]	]	)	)	_	17	amod	_	_
-	-	O	O	Other	###	15	-	-	-	-	_	14	punct	_	_
DEX-binding	JJ	I-NP	O	Other	###	16	DEX-binding	DEX-binding	JJ	JJ	_	17	amod	_	_
assays	NNS	I-NP	O	Other	###	17	assays	assays	NNS	NNS	_	19	nsubjpass	_	_
were	VBD	B-VP	O	Other	###	18	were	were	VBD	VBD	_	19	auxpass	_	_
used	VBN	I-VP	O	Other	###	19	used	used	VBN	VBN	_	2	parataxis	_	_
to	TO	B-VP	O	Other	###	20	to	to	TO	TO	_	21	mark	_	_
measure	VB	I-VP	O	Other	###	21	measure	measure	VB	VB	_	19	xcomp	_	_
,	,	O	O	Other	###	22	,	,	,	,	_	21	punct	_	_
in	FW	B-ADVP	O	Other	###	23	in	in	FW	FW	_	24	compound	_	_
vitro	FW	I-ADVP	O	Other	###	24	vitro	vitro	FW	FW	_	21	advmod	_	_
,	,	O	O	Other	###	25	,	,	,	,	_	21	punct	_	_
the	DT	B-NP	O	Other	###	26	the	the	DT	DT	_	28	det	_	_
GC	NN	I-NP	B-protein	Other	###	27	GC	GC	NN	NN	_	28	compound	_	_
receptor	NN	I-NP	I-protein	Other	###	28	receptor	receptor	NN	NN	_	21	dobj	_	_
affinity	NN	I-NP	O	Other	###	29	affinity	affinity	NN	NN	_	28	dep	_	_
(	(	O	O	Other	###	30	(	(	(	(	_	33	punct	_	_
1	NN	B-NP	O	Other	###	31	1	1	NN	NN	_	29	nummod	_	_
/	/	O	O	Other	###	32	/	/	/	/	_	33	punct	_	_
Kd	NN	B-NP	O	Other	###	33	Kd	Kd	NN	NN	_	29	appos	_	_
)	)	O	O	Other	###	34	)	)	)	)	_	33	punct	_	_
and	CC	O	O	Other	###	35	and	and	CC	CC	_	28	cc	_	_
number	NN	B-NP	O	Other	###	36	number	number	NN	NN	_	28	conj	_	_
(	(	O	O	Other	###	37	(	(	(	(	_	38	punct	_	_
Bmax	NN	B-NP	O	Other	###	38	Bmax	Bmax	NN	NN	_	36	appos	_	_
)	)	O	O	Other	###	39	)	)	)	)	_	38	punct	_	_
in	IN	B-PP	O	Other	###	40	in	in	IN	IN	_	42	case	_	_
mononuclear	JJ	B-NP	B-cell_type	Other	###	41	mononuclear	mononuclear	JJ	JJ	_	42	amod	_	_
leukocytes	NNS	I-NP	I-cell_type	Other	###	42	leukocytes	leukocytes	NNS	NNS	_	28	nmod	_	_
of	IN	B-PP	O	Other	###	43	of	of	IN	IN	_	46	case	_	_
11	CD	B-NP	O	Other	###	44	11	11	CD	CD	_	46	nummod	_	_
MDD	NN	I-NP	O	Other	###	45	MDD	MDD	NN	NN	_	46	compound	_	_
patients	NNS	I-NP	O	Other	###	46	patients	patients	NNS	NNS	_	42	nmod	_	_
and	CC	O	O	Other	###	47	and	and	CC	CC	_	46	cc	_	_
15	CD	B-NP	O	Other	###	48	15	15	CD	CD	_	50	nummod	_	_
control	JJ	I-NP	O	Other	###	49	control	control	JJ	JJ	_	50	amod	_	_
subjects	NNS	I-NP	O	Other	###	50	subjects	subjects	NNS	NNS	_	46	conj	_	_
.	.	O	O	Other	###	51	.	.	.	.	_	2	punct	_	_

No	DT	B-NP	O	Other	###	1	No	No	DT	DT	_	3	neg	_	_
receptor	NN	I-NP	O	Other	###	2	receptor	receptor	NN	NN	_	3	compound	_	_
abnormalities	NNS	I-NP	O	Other	###	3	abnormalities	abnormalities	NNS	NNS	_	5	nsubjpass	_	_
were	VBD	B-VP	O	Other	###	4	were	were	VBD	VBD	_	5	auxpass	_	_
detected	VBN	I-VP	O	Other	###	5	detected	detected	VBN	VBN	_	0	root	_	_
in	IN	B-PP	O	Other	###	6	in	in	IN	IN	_	9	case	_	_
the	DT	B-NP	O	Other	###	7	the	the	DT	DT	_	9	det	_	_
MDD	NN	I-NP	O	Other	###	8	MDD	MDD	NN	NN	_	9	compound	_	_
group	NN	I-NP	O	Other	###	9	group	group	NN	NN	_	5	nmod	_	_
;	:	O	O	Other	###	10	;	;	:	:	_	5	punct	_	_
thus	RB	B-NP	O	Other	###	11	thus	thus	RB	RB	_	32	advmod	_	_
any	DT	I-NP	O	Other	###	12	any	any	DT	DT	_	14	det	_	_
cellular	JJ	I-NP	O	Other	###	13	cellular	cellular	JJ	JJ	_	14	amod	_	_
defect	NN	I-NP	O	Other	###	14	defect	defect	NN	NN	_	32	nsubj	_	_
leading	VBG	B-VP	O	Other	###	15	leading	leading	VBG	VBG	_	14	acl	_	_
to	TO	B-PP	O	Other	###	16	to	to	TO	TO	_	18	case	_	_
a	DT	B-NP	O	Other	###	17	a	a	DT	DT	_	18	det	_	_
lack	NN	I-NP	O	Other	###	18	lack	lack	NN	NN	_	15	nmod	_	_
of	IN	B-PP	O	Other	###	19	of	of	IN	IN	_	20	case	_	_
responsiveness	NN	B-NP	O	Other	###	20	responsiveness	responsiveness	NN	NN	_	18	nmod	_	_
to	TO	B-PP	O	Other	###	21	to	to	TO	TO	_	22	case	_	_
GC	NN	B-NP	O	Other	###	22	GC	GC	NN	NN	_	20	nmod	_	_
in	IN	B-PP	O	Other	###	23	in	in	IN	IN	_	26	case	_	_
the	DT	B-NP	O	Other	###	24	the	the	DT	DT	_	26	det	_	_
MDD	NN	I-NP	O	Other	###	25	MDD	MDD	NN	NN	_	26	compound	_	_
patients	NNS	I-NP	O	Other	###	26	patients	patients	NNS	NNS	_	20	nmod	_	_
,	,	O	O	Other	###	27	,	,	,	,	_	14	punct	_	_
if	IN	B-SBAR	O	Other	###	28	if	if	IN	IN	_	29	mark	_	_
present	NN	B-NP	O	Other	###	29	present	present	NN	NN	_	32	advcl	_	_
,	,	O	O	Other	###	30	,	,	,	,	_	32	punct	_	_
probably	RB	B-ADVP	O	Other	###	31	probably	probably	RB	RB	_	32	advmod	_	_
lies	VBZ	B-VP	O	Other	###	32	lies	lies	VBZ	VBZ	_	5	parataxis	_	_
beyond	IN	B-PP	O	Other	###	33	beyond	beyond	IN	IN	_	37	case	_	_
the	DT	B-NP	O	Other	###	34	the	the	DT	DT	_	37	det	_	_
initial	JJ	I-NP	O	Other	###	35	initial	initial	JJ	JJ	_	37	amod	_	_
receptor	NN	I-NP	O	Other	###	36	receptor	receptor	NN	NN	_	37	compound	_	_
binding	NN	I-NP	O	Other	###	37	binding	binding	NN	NN	_	32	nmod	_	_
.	.	O	O	Other	###	38	.	.	.	.	_	32	punct	_	_

DEX	NN	B-NP	O	Other	###	1	DEX	DEX	NN	NN	_	8	nsubjpass	_	_
(	(	O	O	Other	###	2	(	(	(	(	_	4	punct	_	_
1.0	CD	B-NP	O	Other	###	3	1.0	1.0	CD	CD	_	4	nummod	_	_
mg	NN	I-NP	O	Other	###	4	mg	mg	NN	NN	_	1	dep	_	_
orally	RB	B-ADVP	O	Other	###	5	orally	orally	RB	RB	_	4	advmod	_	_
)	)	O	O	Other	###	6	)	)	)	)	_	4	punct	_	_
was	VBD	B-VP	O	Other	###	7	was	was	VBD	VBD	_	8	auxpass	_	_
administered	VBN	I-VP	O	Other	###	8	administered	administered	VBN	VBN	_	0	root	_	_
to	TO	I-VP	O	Other	###	9	to	to	TO	TO	_	10	mark	_	_
study	VB	I-VP	O	Other	###	10	study	study	VB	VB	_	8	xcomp	_	_
in	FW	B-NP	O	Other	###	11	in	in	FW	FW	_	15	amod	_	_
vivo	FW	I-NP	O	Other	###	12	vivo	vivo	FW	FW	_	11	dep	_	_
GC	NN	I-NP	O	Other	###	13	GC	GC	NN	NN	_	15	compound	_	_
receptor	NN	I-NP	O	Other	###	14	receptor	receptor	NN	NN	_	15	compound	_	_
down-regulation	NN	I-NP	O	Other	###	15	down-regulation	down-regulation	NN	NN	_	10	dobj	_	_
.	.	O	O	Other	###	16	.	.	.	.	_	8	punct	_	_

Compared	VBN	B-PP	O	Other	###	1	Compared	Compared	VBN	VBN	_	5	case	_	_
to	TO	B-PP	O	Other	###	2	to	to	TO	TO	_	5	case	_	_
the	DT	B-NP	O	Other	###	3	the	the	DT	DT	_	5	det	_	_
control	NN	I-NP	O	Other	###	4	control	control	NN	NN	_	5	compound	_	_
group	NN	I-NP	O	Other	###	5	group	group	NN	NN	_	10	advcl	_	_
,	,	O	O	Other	###	6	,	,	,	,	_	10	punct	_	_
fewer	JJR	B-NP	O	Other	###	7	fewer	fewer	JJR	JJR	_	9	amod	_	_
depressed	JJ	I-NP	O	Other	###	8	depressed	depressed	JJ	JJ	_	9	amod	_	_
subjects	NNS	I-NP	O	Other	###	9	subjects	subjects	NNS	NNS	_	10	nsubj	_	_
down-regulated	VBD	B-VP	O	Other	###	10	down-regulated	down-regulated	VBD	VBD	_	0	root	_	_
Bmax	NN	B-NP	O	Other	###	11	Bmax	Bmax	NN	NN	_	10	dobj	_	_
after	IN	B-PP	O	Other	###	12	after	after	IN	IN	_	13	case	_	_
DEX	NN	B-NP	O	Other	###	13	DEX	DEX	NN	NN	_	10	nmod	_	_
.	.	O	O	Other	###	14	.	.	.	.	_	10	punct	_	_

By	IN	B-PP	O	Other	###	1	By	By	IN	IN	_	3	case	_	_
paired	JJ	B-NP	O	Other	###	2	paired	paired	JJ	JJ	_	3	amod	_	_
t-test	NN	I-NP	O	Other	###	3	t-test	t-test	NN	NN	_	6	nmod	_	_
,	,	O	O	Other	###	4	,	,	,	,	_	6	punct	_	_
Bmax	NN	B-NP	O	Other	###	5	Bmax	Bmax	NN	NN	_	6	nsubj	_	_
decreased	VBD	B-VP	O	Other	###	6	decreased	decreased	VBD	VBD	_	0	root	_	_
significantly	RB	B-ADVP	O	Other	###	7	significantly	significantly	RB	RB	_	6	advmod	_	_
in	IN	B-PP	O	Other	###	8	in	in	IN	IN	_	11	case	_	_
the	DT	B-NP	O	Other	###	9	the	the	DT	DT	_	11	det	_	_
control	NN	I-NP	O	Other	###	10	control	control	NN	NN	_	11	compound	_	_
group	NN	I-NP	O	Other	###	11	group	group	NN	NN	_	6	nmod	_	_
but	CC	B-PP	O	Other	###	12	but	but	CC	CC	_	11	cc	_	_
not	RB	B-PP	O	Other	###	13	not	not	RB	RB	_	17	neg	_	_
in	IN	I-PP	O	Other	###	14	in	in	IN	IN	_	17	case	_	_
the	DT	B-NP	O	Other	###	15	the	the	DT	DT	_	17	det	_	_
depressed	JJ	I-NP	O	Other	###	16	depressed	depressed	JJ	JJ	_	17	amod	_	_
group	NN	I-NP	O	Other	###	17	group	group	NN	NN	_	11	conj	_	_
.	.	O	O	Other	###	18	.	.	.	.	_	6	punct	_	_

Receptor	NN	B-NP	O	Other	###	1	Receptor	Receptor	NN	NN	_	2	compound	_	_
number	NN	I-NP	O	Other	###	2	number	number	NN	NN	_	9	nsubj	_	_
on	IN	B-PP	O	Other	###	3	on	on	IN	IN	_	6	case	_	_
the	DT	B-NP	O	Other	###	4	the	the	DT	DT	_	6	det	_	_
control	NN	I-NP	O	Other	###	5	control	control	NN	NN	_	6	compound	_	_
day	NN	I-NP	O	Other	###	6	day	day	NN	NN	_	2	nmod	_	_
did	VBD	B-VP	O	Other	###	7	did	did	VBD	VBD	_	9	aux	_	_
not	RB	I-VP	O	Other	###	8	not	not	RB	RB	_	9	neg	_	_
correlate	VB	I-VP	O	Other	###	9	correlate	correlate	VB	VB	_	0	root	_	_
significantly	RB	B-ADVP	O	Other	###	10	significantly	significantly	RB	RB	_	9	advmod	_	_
with	IN	B-PP	O	Other	###	11	with	with	IN	IN	_	13	case	_	_
the	DT	B-NP	O	Other	###	12	the	the	DT	DT	_	13	det	_	_
degree	NN	I-NP	O	Other	###	13	degree	degree	NN	NN	_	9	nmod	_	_
of	IN	B-PP	O	Other	###	14	of	of	IN	IN	_	16	case	_	_
receptor	NN	B-NP	O	Other	###	15	receptor	receptor	NN	NN	_	16	compound	_	_
down-regulation	NN	I-NP	O	Other	###	16	down-regulation	down-regulation	NN	NN	_	13	nmod	_	_
,	,	O	O	Other	###	17	,	,	,	,	_	13	punct	_	_
severity	NN	B-NP	O	Other	###	18	severity	severity	NN	NN	_	13	conj	_	_
of	IN	B-PP	O	Other	###	19	of	of	IN	IN	_	20	case	_	_
depression	NN	B-NP	O	Other	###	20	depression	depression	NN	NN	_	18	nmod	_	_
or	CC	I-NP	O	Other	###	21	or	or	CC	CC	_	13	cc	_	_
cortisol	NN	I-NP	O	Other	###	22	cortisol	cortisol	NN	NN	_	23	compound	_	_
concentrations	NNS	I-NP	O	Other	###	23	concentrations	concentrations	NNS	NNS	_	13	conj	_	_
across	IN	B-PP	O	Other	###	24	across	across	IN	IN	_	27	case	_	_
all	PDT	B-NP	O	Other	###	25	all	all	PDT	PDT	_	27	det:predet	_	_
the	DT	I-NP	O	Other	###	26	the	the	DT	DT	_	27	det	_	_
subjects	NNS	I-NP	O	Other	###	27	subjects	subjects	NNS	NNS	_	13	nmod	_	_
.	.	O	O	Other	###	28	.	.	.	.	_	9	punct	_	_

These	DT	B-NP	O	Other	###	1	These	These	DT	DT	_	2	det	_	_
results	NNS	I-NP	O	Other	###	2	results	results	NNS	NNS	_	5	nsubj	_	_
do	VBP	B-VP	O	Other	###	3	do	do	VBP	VBP	_	5	aux	_	_
not	RB	I-VP	O	Other	###	4	not	not	RB	RB	_	5	neg	_	_
lend	VB	I-VP	O	Other	###	5	lend	lend	VB	VB	_	0	root	_	_
support	NN	B-NP	O	Other	###	6	support	support	NN	NN	_	5	dobj	_	_
to	TO	B-PP	O	Other	###	7	to	to	TO	TO	_	9	case	_	_
previous	JJ	B-NP	O	Other	###	8	previous	previous	JJ	JJ	_	9	amod	_	_
reports	NNS	I-NP	O	Other	###	9	reports	reports	NNS	NNS	_	5	nmod	_	_
suggesting	VBG	B-VP	O	Other	###	10	suggesting	suggesting	VBG	VBG	_	9	acl	_	_
that	IN	B-SBAR	O	Other	###	11	that	that	IN	IN	_	16	mark	_	_
GC	NN	B-NP	O	Other	###	12	GC	GC	NN	NN	_	13	compound	_	_
resistance	NN	I-NP	O	Other	###	13	resistance	resistance	NN	NN	_	16	nsubj	_	_
in	IN	B-PP	O	Other	###	14	in	in	IN	IN	_	15	case	_	_
MDD	NN	B-NP	O	Other	###	15	MDD	MDD	NN	NN	_	13	nmod	_	_
results	VBZ	B-VP	O	Other	###	16	results	results	VBZ	VBZ	_	10	ccomp	_	_
from	IN	B-PP	O	Other	###	17	from	from	IN	IN	_	23	case	_	_
a	DT	B-NP	O	Other	###	18	a	a	DT	DT	_	23	det	_	_
GC	NN	I-NP	O	Other	###	19	GC	GC	NN	NN	_	23	compound	_	_
receptor	JJ	I-NP	O	Other	###	20	receptor	receptor	JJ	JJ	_	23	compound	_	_
-	-	O	O	Other	###	21	-	-	-	-	_	23	punct	_	_
binding	JJ	I-NP	O	Other	###	22	binding	binding	JJ	JJ	_	23	compound	_	_
abnormality	NN	I-NP	O	Other	###	23	abnormality	abnormality	NN	NN	_	16	nmod	_	_
,	,	O	O	Other	###	24	,	,	,	,	_	5	punct	_	_
and	CC	O	O	Other	###	25	and	and	CC	CC	_	5	cc	_	_
they	PRP	B-NP	O	Other	###	26	they	they	PRP	PRP	_	27	nsubj	_	_
emphasize	VBP	B-VP	O	Other	###	27	emphasize	emphasize	VBP	VBP	_	5	conj	_	_
the	DT	B-NP	O	Other	###	28	the	the	DT	DT	_	29	det	_	_
importance	NN	I-NP	O	Other	###	29	importance	importance	NN	NN	_	27	dobj	_	_
of	IN	B-PP	O	Other	###	30	of	of	IN	IN	_	31	mark	_	_
considering	VBG	B-VP	O	Other	###	31	considering	considering	VBG	VBG	_	29	acl	_	_
receptor	NN	B-NP	O	Other	###	32	receptor	receptor	NN	NN	_	33	compound	_	_
studies	NNS	I-NP	O	Other	###	33	studies	studies	NNS	NNS	_	31	dobj	_	_
in	IN	B-PP	O	Other	###	34	in	in	IN	IN	_	36	case	_	_
the	DT	B-NP	O	Other	###	35	the	the	DT	DT	_	36	det	_	_
context	NN	I-NP	O	Other	###	36	context	context	NN	NN	_	31	nmod	_	_
of	IN	B-PP	O	Other	###	37	of	of	IN	IN	_	42	case	_	_
GC	JJ	B-NP	O	Other	###	38	GC	GC	JJ	JJ	_	42	amod	_	_
-	-	O	O	Other	###	39	-	-	-	-	_	38	punct	_	_
mediated	JJ	B-NP	O	Other	###	40	mediated	mediated	JJ	JJ	_	38	dep	_	_
cell	NN	I-NP	O	Other	###	41	cell	cell	NN	NN	_	42	compound	_	_
processes	NNS	I-NP	O	Other	###	42	processes	processes	NNS	NNS	_	36	nmod	_	_
in	IN	B-SBAR	O	Other	###	43	in	in	IN	IN	_	46	mark	_	_
order	NN	O	O	Other	###	44	order	order	NN	NN	_	43	mwe	_	_
to	TO	B-VP	O	Other	###	45	to	to	TO	TO	_	46	mark	_	_
identify	VB	I-VP	O	Other	###	46	identify	identify	VB	VB	_	31	advcl	_	_
the	DT	B-NP	O	Other	###	47	the	the	DT	DT	_	52	det	_	_
exact	JJ	I-NP	O	Other	###	48	exact	exact	JJ	JJ	_	52	amod	_	_
cellular	JJ	I-NP	O	Other	###	49	cellular	cellular	JJ	JJ	_	52	amod	_	_
defect	NN	I-NP	O	Other	###	50	defect	defect	NN	NN	_	52	compound	_	_
(	(	I-NP	O	Other	###	51	(	(	(	(	_	52	punct	_	_
s	NNS	I-NP	O	Other	###	52	s	s	NNS	NNS	_	46	dobj	_	_
)	)	O	O	Other	###	53	)	)	)	)	_	52	punct	_	_
leading	VBG	B-VP	O	Other	###	54	leading	leading	VBG	VBG	_	52	acl	_	_
to	TO	B-PP	O	Other	###	55	to	to	TO	TO	_	57	case	_	_
GC	NN	B-NP	O	Other	###	56	GC	GC	NN	NN	_	57	compound	_	_
resistance	NN	I-NP	O	Other	###	57	resistance	resistance	NN	NN	_	54	nmod	_	_
.	.	O	O	Other	###	58	.	.	.	.	_	5	punct	_	_

